Monday, September 6, 2010
Have You Heard About This Heart Valve Replacement Option?Learn more and see if you qualify now!

Starlix, Diovan Not Effective in High-Risk Patients: Study

(Reuters) UPDATED 2010-03-14
Results from a new large study have found that the diabetes drug Starlix (nateglinide) is not effective at slowing diabetes progression or reducing the risk of serious heart trouble in people at high risk for both heart disease and diabetes. Also in the study, researchers found that the blood pressure drug Diovan (valsartan) reduced the progression of diabetes by 14 percent when compared to a placebo, but it did not reduce the risk of serious cardiac problems such as stroke and heart attack in these patients.   Read full story >
See all Heart Disease News

People who read this also read...